San Francisco, California, USA
Polaris Insight Center • Psychedelic Science Review • California Institute of Integral Studies • Healing Realms • Ceremony Health • CIIS Center for Psychedelic Therapies and Research • Women's Visionary Congress • Cognitive Freedom Alliance • KRIYA Institute (Ketamine Research Institute) • Total Brain • Business Trip • Psychedelic News Wire • Harris Bricken • The CSP Fund of the San Francisco Foundation • Stupski Foundation • University of California, San Francisco • California Pacific Medical Center Research Institute • Imago BioSciences,Inc. • Medivation, Inc. • Calyx Law • Jaguar Health • Clark Howell • Heally • Braintrust • HealthMode • Forest Medicine Coaching • Erie Vision • My Doctor Medical Group • MindPeace Clinics
Apeiron Investment Group • Future Ventures • Lightspeed Venture Partners • MAZAKALI • New Enterprise Associates (NEA) • Tao Capital Partners • Y Combinator • General Catalyst • Arch Venture Partners • Foresite Capital • Fearless Ventures • Woodline Partners • PsyMed Ventures • Vine Ventures • Gaingels
Fabian Hansen • Maryanna Saenko • Steve Jurvetson • Will Kohler • Ravi Mhatre • Andrew Moley • Meredith Kendall • Craig Piatti • Sumit Mehta • Jon Sakoda • Aaron Jacobson • Colin Bryant • Shanna Hendriks • Joby Pritzker • Kirsty Nathoo • Dalton Caldwell • Verena Prescher • Stephanie Simon • Michael Seibel • Anu Hariharan • Miriam Volat • Matias Serebrinsky • Greg Kubin • Rui Ma • Gregory Roufa • David Glowacki
Director of Scientific Research and Partnerships • Anyone • Product Manager • Engineering Manager • Data Scientist • Director of Funder Engagement • Executive Assistant (Center for Psychedelic Therapies and Research) • Instruction Supervisor • Curriculum and Instruction - Faculty Position • Executive Assistant • Center Manager - Psychedelic Therapies and Research • Executive Communications and Operations Coordinator • Development Associate • Project Associate • Impact Manager • Psychologist Advisor (Psychedelics) • Mental Health Coach (Psychedelics) • Center Manager- Psychedelic Therapies and Research • Instruction Associate- Psychedelic Therapies and Research • Logistics Coordinator - Psychedelic Therapies and Research • Admissions and Enrollment Manager- Psychedelic Therapies and Research • Admissions and Enrollment Manager- Psychedelic Therapies and Research • Center Manager - Psychedelic Therapies and Research • Instruction Associate- Psychedelic Therapies and Research • Mentor Director and Instruction Supervisor- Center of Psychedelic therapies and Research
A Study of Psilocybin for Major Depressive Disorder (MDD) • Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors • MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function • Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD • Study of the Effects of MDMA/Ecstasy on Water Regulation, Sleep, and Cognition. • A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) • Role of Serotonin in Acute and Subacute MDMA Effects • A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD • Acute Pain Management in Patients on Opioid Replacement Therapy • Pediatric Laser Acupuncture and Renal Biopsy • A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD • Long-Term Safety and Effectiveness of Manualized MDMA-Assisted Therapy for the Treatment of Posttraumatic Stress Disorder • Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine] • Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease • Psilocybin Therapy for Depression in Bipolar II Disorder • Comparing the Effects of Psilocin and Psilocybin in Healthy Adults • Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use